Clinical Study of the Third Dose Immunization Schedule of COVID-19 Inactivated Vaccine, (Vero Cells) in Adults Aged 18 Years and Above

NCT05164731 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

880

Enrollment

OTHER

Sponsor class

Conditions

SARS-CoV2 Infection

Interventions

BIOLOGICAL: SARS-CoV-2 Vaccine, Inactivated (Vero Cell)

Sponsor

Chinese Academy of Medical Sciences

Collaborators

[object Object]